A case of anaplastic clear-cell ependymoma presenting with high erythropoietin concentration and 1p/19q deletions

被引:2
|
作者
Asano, Kenichiro [1 ]
Kudo, Kanae [1 ]
Mori, Fumiaki [2 ]
Ohkuma, Hiroki [1 ]
Wakabayashi, Koichi [2 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Neurosurg, Aomori 0368562, Japan
[2] Hirosaki Univ, Grad Sch Med, Dept Neuropathol, Inst Brain Sci, Hirosaki, Aomori, Japan
关键词
Anaplastic clear-cell ependymoma; Erythropoietin; 1p/19q deletions; LEPTOMENINGEAL HEMANGIOBLASTOMA; EXPRESSION; RECEPTOR; TUMORS; IMMUNOREACTIVITY; PATTERNS; SURVIVAL; GRADE;
D O I
10.1007/s10014-011-0043-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We describe a 19-year-old woman with onset of epileptic seizure, and a small mural nodule and multicystic lesions with severe brain edema located in the right frontal lobe. At surgery, the tumor and a clear margin was removed, and symptoms improved postoperatively. Extended local radiotherapy (60 Gy) was performed. Histopathological examination revealed oligodendroglioma-like tumor cells with a perinuclear halo. The tumor cells extended processes toward CD34-positive proliferating vessels, which resemble a basement membrane. These proliferating vessels formed a tumor membrane so that there was a clear margin between the tumor and brain tissue. Tumor cells were positive for epithelial membrane antigen in a dot-like pattern. MIB-1 staining index was 50.6%. Electron microscopy showed cilia and zipper-like junctions, and anaplastic clear-cell ependymoma grade III was diagnosed. A characteristic of the case was formation of a tumor membrane by proliferating tumor blood vessels. Fluorescence in situ hybridization showed 1p/19q deletions, and the concentration of erythropoietin in the cyst fluid was abnormally high, at 1,859.4 mIU/ml. Erythropoietin and erythropoietin receptors were verified with immunohistochemical staining.
引用
收藏
页码:317 / 327
页数:11
相关论文
共 50 条
  • [21] AN ANAPLASTIC OLIGODENDROGLIOMA CELL LINE HARBORING AN UNBALANCED TRANSLOCATION THAT MEDIATES THE LOSS OF CHROMOSOMAL ARMS 1P AND 19Q
    Kelly, John
    Blough, Michael
    Stechishin, Owen
    Chojnacki, Andrew
    Perizzolo, Marco
    Steele, Lisa
    Auer, Roland
    Hader, Walter
    Demetrick, Douglas
    Parney, Ian
    Jenkins, Robert B.
    Cairncross, J. Gregory
    Weiss, Samuel
    NEURO-ONCOLOGY, 2008, 10 (05) : 847 - 847
  • [22] Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report
    Mickaël Burgy
    Marie-Pierre Chenard
    Georges Noël
    Khalil Bourahla
    Roland Schott
    Journal of Medical Case Reports, 13
  • [23] Polysomy For Chromosomes 1 And 19 Predicts Earlier Recurrence In Anaplastic Oligodendrogliomas With Concurrent 1p/19q Loss
    Snuderl, Matija
    Eichler, April
    Ligon, Keith
    Vu, Quynh
    Silver, Michael
    Betensky, Rebecca
    Ligon, Azra
    Wen, Patrick
    Louis, David
    Iafrate, A.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 562 - 563
  • [24] Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss
    Snuderl, Matija
    Eichler, April F.
    Ligon, Keith L.
    Vu, Quynh U.
    Silver, Michael
    Betensky, Rebecca A.
    Ligon, Azra H.
    Wen, Patrick Y.
    Louis, David N.
    Iafrate, A. John
    CLINICAL CANCER RESEARCH, 2009, 15 (20) : 6430 - 6437
  • [25] Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component
    Hiroaki Takeuchi
    Toshihiko Kubota
    Ryuhei Kitai
    Ken Matsuda
    Norichika Hashimoto
    Kazufumi Sato
    Journal of Neuro-Oncology, 2009, 91
  • [26] Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component
    Takeuchi, Hiroaki
    Kubota, Toshihiko
    Kitai, Ryuhei
    Matsuda, Ken
    Hashimoto, Norichika
    Sato, Kazufumi
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (01) : 33 - 38
  • [27] DNA extraction by FTA™ technology:: application for rapid detection of 1p/19q deletions in gliomas
    Fontaine, D.
    Monnot, S.
    Vandenbos, F.
    Paquis, P.
    Michiels, J.-F.
    Bannwarth, S.
    Paquis-Flucklinger, V.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2007, 33 (03) : 360 - 363
  • [28] A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q in human oligodendrogliomas.
    Jenkins, Robert B.
    Blair, Hilary
    Flynn, Heather
    Passe, Sandra
    Law, Mark
    Ballman, Karla V.
    Aldape, Ken
    Giannini, Caterina
    Buckner, Jan C.
    CANCER RESEARCH, 2006, 66 (08)
  • [29] PROGNOSTIC VALUE OF MGMT METHYLATION STATUS IN PATIENTS WITH 1P/19Q INTACT ANAPLASTIC GLIOMAS
    Franceschi, Enrico
    Tosoni, Alicia
    Ermani, Mario
    Sturiale, Carmelo
    Dall'Occa, Patrizia
    Pession, Annalisa
    Di Oto, Enrico
    Morandi, Luca
    Bartolini, Stefania
    Brandes, Alba A.
    ANNALS OF ONCOLOGY, 2009, 20
  • [30] Recurrent anaplastic oligodendroglioma with 1p/19q loss and a progressive increase in p53 immunoreactivity: Case study.
    Nathoo, N
    Commane, M
    Varma, A
    Chernova, OB
    Stevens, G
    Staugaitis, S
    Vogelbaum, M
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (05): : 539 - 539